Business
Biotech IPO fundraising success: Seaport’s $255M Upsized IPO
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized U.S. initial public offering…